在肺癌中准COMMD4-H2B蛋白质复合体
Ming Tang1,2, Joshua T Burgess1,3, Mark Fisher1
1Queensland University of Technology (QUT), School of Biomedical Sciences, Centre for Genomics and Personalised Health at the Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, 4102, Australia.
British journal of cancer
|November 2, 2023
概括
研究人员通过开发一种可以破坏COMMD4-H2B相互作用的来确定非小细胞肺癌 (NSCLC) 的新型治疗,从而增强癌细胞对辐射的敏感性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 肺癌是全球癌症死亡的主要原因,非小细胞肺癌 (NSCLC) 是最常见的亚型.
- 药物耐药性限制了化疗的有效性,需要确定NSCLC的新型治疗点.
- 在NSCLC中,COMMD4已成为潜在的治疗点.
研究的目的:
- 阐明COMMD4和H2B之间的结合相互作用.
- 设计一种能够破坏COMMD4-H2B相互作用的短H2B.
- 调查开发的是否可以模拟NSCLC中COMMD4siRNA枯竭的影响.
主要方法:
- 利用分子建模来预测COMMD4-H2B结合的位置.
- 采用体外结合试验和局部定向突变发生法来验证结合并开发.
- 在NSCLC细胞系中通过细胞活力,DNA修复和线性灾难测定来评估的疗效.
主要成果:
- 成功识别了COMMD4-H2B结合姿势,并开发了一种抑制这种相互作用的H2B,在体外和体内.
- 证明该在H2B结合部位直接与COMMD4结合.
- 观察到用治疗的NSCLC细胞表现出对电离辐射的敏感性增加,DNA双链断裂升高,并诱导了线性灾难.
结论:
- COMMD4-H2B相互作用代表了非小细胞肺癌的一个有前途的新疗法标.
- 开发的H2B显示出作为NSCLC治疗剂的潜力,特别是与放射治疗结合使用.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K